Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMARCA4 | P51532 | 6/20 | 0.58 |
| ▸ | PBRM1 | Q86U86 | 4/20 | 0.55 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.52 |
| ▸ | TUBB4A | P04350 | 5/20 | 0.48 |
| ▸ | TUBB | P07437 | 5/20 | 0.48 |
| ▸ | TUBA3C | P0DPH7 | 5/20 | 0.48 |
| ▸ | TUBA1B | P68363 | 5/20 | 0.48 |
| ▸ | TUBA4A | P68366 | 5/20 | 0.48 |
| ▸ | TUBB4B | P68371 | 5/20 | 0.48 |
| ▸ | TUBB3 | Q13509 | 5/20 | 0.48 |
| ▸ | TUBB2A | Q13885 | 5/20 | 0.48 |
| ▸ | TUBB8 | Q3ZCM7 | 5/20 | 0.48 |
| ▸ | TUBA3E | Q6PEY2 | 5/20 | 0.48 |
| ▸ | TUBA1A | Q71U36 | 5/20 | 0.48 |
| ▸ | TUBA1C | Q9BQE3 | 5/20 | 0.48 |
| ▸ | TUBB6 | Q9BUF5 | 5/20 | 0.48 |
| ▸ | TUBB2B | Q9BVA1 | 5/20 | 0.48 |
| ▸ | TUBB1 | Q9H4B7 | 5/20 | 0.48 |
| ▸ | NPC1 | O15118 | 2/20 | 0.46 |
| ▸ | RAB9A | P51151 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13977272 | 0.81 | RAB9A (0.60) | SMARCA4PBRM1ALOX5TUBB4ATUBB | |
| SCHEMBL21993283 | 0.79 | SMARCA4 (0.60) | SMARCA4PBRM1ALOX5TUBB4ATUBB | |
| SCHEMBL21992770 | 0.79 | SMARCA4 (0.60) | SMARCA4PBRM1ALOX5TUBB4ATUBB | |
| SCHEMBL21992769 | 0.78 | SMARCA4 (0.64) | SMARCA4PBRM1NPC1RAB9ACYP1A2 | |
| SCHEMBL21992956 | 0.78 | MEN1 (0.61) | SMARCA4PBRM1ALOX5TUBB4ATUBB | |
| SCHEMBL21992767 | 0.78 | CCR3 (0.63) | SMARCA4PBRM1ALOX5NPC1RAB9A | |
| SCHEMBL21992968 | 0.77 | SMARCA4 (0.57) | SMARCA4PBRM1ALOX5TUBB4ATUBB | |
| SCHEMBL21931930 | 0.76 | ALOX5 (0.63) | SMARCA4PBRM1ALOX5TUBB4ATUBB | |
| SCHEMBL21992773 | 0.75 | SMARCA4 (0.57) | SMARCA4PBRM1ALOX5TUBB4ATUBB | |
| SCHEMBL25053623 | 0.75 | RAB9A (0.62) | SMARCA4PBRM1ALOX5TUBB4ATUBB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11583530-B2 | Compounds for the prevention and treatment of medical disorders and uses thereof | GALECTIN SCIENCES, LLC (US) | 2023-02-21 | — | — | US | disclosed |
| US-20200147088-A1 | Compounds for the Prevention and Treatment of Medical Disorders and Uses Thereof | GALECTIN SCIENCES, LLC | 2020-05-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200147088-A1 | Compounds for the Prevention and Treatment of Medical Disorders and Uses Thereof | LGALS1, LGALS2, LGALS3 | SMARCA4 4569/4885PBRM1 4399/4885ALOX5 570/4885 |
| US-11583530-B2 | Compounds for the prevention and treatment of medical disorders and uses thereof | LGALS1, LGALS2, LGALS3 | SMARCA4 4569/4885PBRM1 4399/4885ALOX5 570/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.